The Vanguard Total Stock Market ETF ($VTI), which provides broad exposure to the entire U.S. stock market, is rising in ...
The Vanguard Total Stock Market ETF ($VTI) provides investors with broad access to the entire U.S. stock market. In today’s ...
These agreements are designed to be a flexible financing solution to support operations while finalizing a strategic partnership Company is in advanced stages to finalize a strategic transaction with ...
SAN DIEGO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...
Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of achieving accelerated approval followed by full ...
Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of achieving accelerated approval followed by full ...
BioAtla, Inc. (NASDAQ:BCAB), a clinical-stage biopharmaceutical company specializing in the development of conditionally active biologics (CABs) for the treatment of cancer, finds itself at a critical ...
Good day, everyone, and welcome to the BioAtla Second Quarter 2025 Earnings Call. [Operator Instructions] And it is my pleasure to turn today's conference over to Kristy Grabowski with Life Science ...
BioAtla reported better-than-expected financial results in Q1 2025, with an EPS of -$0.26 beating the forecast of -$0.39. This improvement was driven by significant cost reductions, with R&D expenses ...
an improvement over the prior year’s $(0.44) (GAAP, Q2 2024). Operating expenses (GAAP) declined year over year, but cash reserves dropped sharply to $18.2 million by June 30, 2025. Advancement in ...
The press release with the financial results will be accessible prior to the conference call through “News Releases” in the News & Events section of the company’s website. A replay of the call will ...